Showing results (171-180 of 342) with videos related to
Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2015
A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013Ian Nivison-Smith, Peter Bardy, Anthony J Dodds, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality riskIan Nivison-Smith, Anthony J Dodds, Jason Butler, et al.Journal of Clinical Medicine|October 17, 2019
Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher DiseaseTama Dinur, Ari Zimran, Michal Becker-Cohen, et al.Blood Cells, Molecules & Diseases|November 15, 2016
Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imigluceraseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.European Journal of Haematology|January 31, 2022
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Axel Glasmacher, Peng Liu, et al.Blood Cells, Molecules & Diseases|January 25, 2011
Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genesEva Svobodová, Lenka Mrázová, Ondřej Lukšan, et al.American Journal of Hematology|April 1, 2004
Rheological determinants in patients with Gaucher disease and internal inflammationAri Zimran, Amir Bashkin, Deborah Elstein, et al.International Journal of Molecular Sciences|February 25, 2023
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher DiseaseTama Dinur, Peter Bauer, Christian Beetz, et al.Internal Medicine Journal|November 11, 2018
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiativeAtul Mehta, David J Kuter, Sam S Salek, et al.Blood Cells, Molecules & Diseases|June 11, 2016
Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher diseaseGregory M Pastores, Hadhami Ben Turkia, Derlis E Gonzalez, et al.Pageof 35